info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Digital Respiratory Devices Market Size

ID: MRFR//10316-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

Conventional inhalers have long been the stalwart devices for delivering doses to asthma or Chronic Obstructive Pulmonary Disease (COPD) patients. However, a transformative wave is sweeping through respiratory care with the advent of Smart Inhalers. These innovative devices go beyond the traditional inhalers by incorporating sensors into metered dose inhalers, revolutionizing the way patients manage their conditions. Smart Inhalers not only record dosage and frequency but also feature integrated apps that serve as companions in a patient's respiratory journey, offering reminders, usage guidance, and valuable insights into their symptoms.

The fundamental distinction between conventional inhalers and Smart Inhalers lies in their capabilities and the level of engagement they facilitate for patients managing respiratory conditions. Conventional inhalers, while effective in delivering medication, lack the sophisticated features that empower patients to actively participate in their care. On the other hand, Smart Inhalers harness the power of technology to provide a comprehensive and personalized approach to respiratory management.

At the core of Smart Inhalers is the integration of sensors into the traditional metered dose inhalers. These sensors record crucial information such as dosage and the frequency of medication use. This data, once collected, serves as a valuable tool for both patients and healthcare providers. It allows for precise tracking of medication adherence, providing insights into whether patients are following their prescribed treatment plans. This real-time monitoring is a game-changer, enabling healthcare professionals to intervene promptly if deviations or issues arise.

The transformative potential of Smart Inhalers extends beyond basic data recording. The integration of smartphone apps amplifies their impact by creating a seamless and user-friendly experience for patients. These apps offer a range of functionalities designed to enhance patient engagement and facilitate effective self-management of respiratory conditions.

One key feature of Smart Inhaler apps is the ability to send reminders to patients, ensuring that they adhere to their prescribed dosage schedules. This simple yet powerful function addresses one of the significant challenges in respiratory care—medication adherence. Forgetting to take medications as prescribed can lead to exacerbations of symptoms and a decline in overall respiratory health. Smart Inhaler apps act as vigilant companions, sending timely reminders to patients and helping them stay on track with their treatment plans.

Beyond reminders, Smart Inhaler apps provide invaluable assistance in the usage of the device itself. Many patients, especially those newly diagnosed, may struggle with the proper inhalation technique. Smart Inhaler apps often feature instructional guides and visual aids, helping patients master the correct inhalation technique. This guidance contributes to the overall effectiveness of the treatment, ensuring that patients receive the full benefit of their prescribed medications.

Perhaps one of the most significant advantages offered by Smart Inhalers is the empowerment of patients to monitor and understand their symptoms. Unlike conventional inhalers, Smart Inhalers enable patients to log and track their symptoms, creating a comprehensive record over time. This data becomes a valuable resource during medical consultations, allowing patients to provide detailed insights into their respiratory health. It also facilitates a proactive approach to care, as patients can identify patterns or triggers associated with their symptoms, fostering a deeper understanding of their condition.

The personalized insights provided by Smart Inhalers empower patients to become active participants in their healthcare journey. By recognizing patterns in their symptoms and understanding the factors influencing their respiratory health, patients gain a sense of control and autonomy over their conditions. This level of engagement is a paradigm shift from the passive role often associated with traditional inhaler usage.

As the healthcare landscape evolves, the role of technology in respiratory care becomes increasingly pivotal. Smart Inhalers, with their combination of sensor technology and integrated apps, represent a significant leap forward in enhancing patient outcomes and reshaping the approach to managing respiratory conditions. From precise medication tracking to personalized insights and guidance, Smart Inhalers offer a holistic solution that transcends the limitations of conventional inhalers.

In conclusion, the emergence of Smart Inhalers marks a transformative chapter in respiratory care. These innovative devices bridge the gap between traditional inhalers and advanced technology, providing patients with a comprehensive and personalized approach to managing asthma and COPD. With their ability to record dosage, offer reminders, provide usage guidance, and empower patients with insights into their symptoms, Smart Inhalers are poised to redefine the standard of care in respiratory health. As the healthcare industry continues to embrace digital solutions, Smart Inhalers stand as a beacon of innovation, offering a brighter and more empowered future for individuals navigating the complexities of respiratory conditions.

Covered Aspects:

Report Attribute/Metric Details
Market Size Value In 2022 USD 36.5 Billion
Market Size Value In 2023 USD 45.8 Billion
Growth Rate 25.50% (2023-2032)

Global Digital Respiratory Devices Market Overview


The Digital Respiratory Devices Market Size was valued at USD 36.5 Billion in 2022 and is projected to grow from USD 45.8 Billion in 2023 to USD 281.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 25.50% during the forecast period (2023 - 2032). Rising rates of respiratory conditions include COPD, TB, asthma, and sleep apnea, as well as technology improvements and an increase in homecare applications, are the key market drivers enhancing the market growth.

Digital Respiratory Devices Market1


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Digital Respiratory Devices Market Trends



  • Increasing prevalence of respiratory disorders, such as COPD, TB, asthma, and sleep apnea is driving the market growth


The considerable rise in the prevalence of severe chronic respiratory diseases (CRDs) like bronchial asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, lung disorders, and pulmonary hypertension (PH) is responsible for the market growth. A growing senior population, tobacco usage, increased air pollution, and occupational exposure to dust in the mining, forestry, and agricultural industries all contribute to a steadily rising risk of acquiring CRDs. As a result, the market for respiratory management tools is expanding quickly. Clinical testing, regulatory processes, and post-approval operations have become more difficult as a result of the COVID-19 pandemic. This is primarily due to challenges with patient enrollment, treatment, and recruitment for clinical research.


However, it is projected that the use of smart inhalers will rise in the post-pandemic era as healthcare providers resort to linked medical devices to guarantee that patients receive the best care and advice available, regardless of the situation. This is due to the fact that many patients suffered since they were unable to receive consultations and treatments in person due to the pandemic's restrictions. 


The pandemic illustrated just how deadly respiratory infections and diseases can become if not promptly and adequately managed. According to the research that is currently available, digital inhalers help asthma and COPD patients better manage their medications and receive direct clinical care. The benefits of improved medication adherence have the potential to improve clinical outcomes and reduce the need for more expensive or complex therapies like biologics.


Additionally, positive results were seen with the usage of Adherium's smart inhaler system in a 12-month controlled research that was carried out in January 2017 at the Sheffield Children's Hospital in the United Kingdom. Less hospitalizations, better medication adherence, and fewer doctor visits were some of the beneficial medical outcomes. The global market is being driven by an increasing number of key developments in digital respiratory technology. For instance, FindAir medical's FindAir ONE smart inhaler device, which has received CE certification, is available to the general public in Europe as of January 2019. 


To increase the effectiveness of drug management, an increasing number of enterprises are adding digital technologies into their products. For instance, HeroTracker Sense was introduced by Aptar Pharma in April 2022. A standard metered dosage inhaler (pMDI) is transformed into a smart linked healthcare device by this revolutionary digital respiratory health solution. Thus, driving the Digital Respiratory Devices market revenue.


Digital Respiratory Devices Market Segment Insights


Digital Respiratory Devices Product Insights


The Market segments of Digital Respiratory Devices, based on Product, includes smart inhalers & nebulizers and sensors & apps. Smart inhalers & nebulizers segment dominated the global market in 2022. It is anticipated that the rising air pollution levels, increasing prevalence of asthma and other respiratory diseases, and expanding desire for digital respiratory devices would all contribute to this demand. Furthermore, it has been demonstrated that individuals with COPD and asthma adhere more frequently while using smart inhalers. Smart inhalers also offer more effective assistance and keep track of the medicine inhalation approach when compared to traditional inhalers.


Digital Respiratory Devices Indication Insights


The Digital Respiratory Devices Market segmentation, based on Indication, includes asthma, COPD, and other diseases. COPD segment dominated the global market in 2022. 200 million individuals worldwide suffer with COPD.  Additionally, respiratory disorders account for slightly more than 8% of all chronic diseases worldwide. By 2030, COPD will overtake ischemic heart disease and HIV/AIDS to become the fourth-leading causes of mortality, according to a World Health Organization projection made in 2020.


Digital Respiratory Devices Distribution Channel Insights


The Market segmentation of Digital Respiratory Devices, based on Distribution Channel, includes hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies segment dominated the Digital Respiratory Devices Market in 2022. The elderly population frequently receives medical care for a variety of chronic respiratory ailments, and they buy medication for these conditions from hospital pharmacies. Hospital pharmacies also provide medical staff with medication supplies so that patients can get their drugs quickly.


Digital Respiratory Devices End Use Insights


The Market segmentation of Digital Respiratory Devices, based on End Use, includes hospitals, homecare settings, and other settings. Hospitals segment dominated the Digital Respiratory Devices Market in 2022. Over the coming years, increased public-private partnerships, quick advancements in healthcare infrastructure, and greater access to healthcare services are all expected to cause a major increase in the market for hospitals. Hospitals, homecare settings, and other settings make up the market segments.


Figure 1: Digital Respiratory Devices Market, by End Use, 2022 & 2032 (USD Billion)


Digital Respiratory Devices Market, by End Use, 2022 & 2032 (USD Billion)


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Digital Respiratory Devices Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Digital Respiratory Devices Market dominated this market in 2022 (45.80%). Asthma, COPD, and other chronic respiratory disorders are becoming more prevalent, which is the cause of this. More than 25 million Americans suffer with asthma. 


Additionally, 14.8 million individuals in the United States have COPD, and the disease claims the lives of 150,000 Americans each year, or one every four minutes. Further, the U.S. market of Digital Respiratory Devices held the largest market share, and the Canada market of Digital Respiratory Devices was the fastest growing market in the North America region.Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: DIGITAL RESPIRATORY DEVICES MARKET SHARE BY REGION 2022 (USD Billion)


DIGITAL RESPIRATORY DEVICES MARKET SHARE BY REGION 2022 (USD Billion)


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Digital Respiratory Devices market accounted for the healthy market share in 2022. During the projection period, it is anticipated that significant advancements in digital respiratory products and their rising acceptance and accuracy will drive market expansion. Further, the German market of Digital Respiratory Devices held the largest market share, and the U.K market of Digital Respiratory Devices was the fastest growing market in the European region


The Asia Pacific Digital Respiratory Devices market is expected to register significant growth from 2023 to 2032. Growing COPD and asthma incidence rates in China and India are mainly blame for this expansion. The number one cause of impairment in China is COPD, which is also a significant public health concern. AstraZeneca's Bevespi Aerosphere, which is used to treat COPD symptoms such chronic bronchitis and/or emphysema, obtained approval in China in May 2020. Moreover, China’s market of Digital Respiratory Devices held the largest market share and the Indian market of Digital Respiratory Devices was the fastest growing market in the Asia-Pacific region.


Digital Respiratory Devices Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the market of Digital Respiratory Devices, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Digital Respiratory Devices industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Digital Respiratory Devices industry to benefit clients and increase the market sector. In recent years, the Digital Respiratory Devices industry has offered some of the most significant advantages to medicine. 


Major players in the Digital Respiratory Devices market, including COHERO Health Inc, Cognita Labs, Adherium Limited, Amiko Digital Health Limited, Teva Pharmaceuticals Industries Ltd., Propeller Health, Novartis AG, Pneuma Respiratory Inc., 3M Health Care Limited, AireHealth, Inc., and FindAir Sp. z o.o, are attempting to increase market demand by investing in research and development Products.


A healthcare firm called Novartis AG (Novartis) specializes in the development, production, and marketing of prescription and over-the-counter medicines, as well as products for eye care. In addition to others, it offers medicines for the treatment of solid tumors, immunological disorders, infections, cardiovascular illness, dermatological issues, neurological disorders, ophthalmic and respiratory diseases, cancer, and neurological disorders. 


Through Sandoz, the business provides biosimilars and generic medications. Through the Novartis Institutes for BioMedical Research (NIBR), Novartis carries out research in a number of disease-related fields. In the Americas, Europe, the Middle East, Africa, and Asia-Pacific, the corporation has a network of subsidiaries and offices. Basel, Switzerland serves as the headquarters of Novartis.


AstraZeneca Plc (AstraZeneca) is a biopharmaceutical firm that focuses on the development, manufacturing, and marketing of a variety of prescription medications. It creates goods for the treatment of ailments like cancer, autoimmune, infectious, neurological, and respiratory, cardiovascular, renal, and metabolic problems. Vaccines, prescription medications, and biologics are all part of the company's product line. Through distributors, local representative offices, and wholly-owned local marketing firms, AstraZeneca offers its products. 


The business sells its goods to general practitioners and specialists in medicine. Operating regions for the corporation include Europe, the Americas, Asia, Africa, and Australasia. The U.K.'s Cambridge, in Cambridgeshire, serves as the company's headquarters. AstraZeneca's Bevespi Aerosphere, which is used to treat COPD symptoms such chronic bronchitis and/or emphysema, obtained approval in China in May 2020.


Key Companies in the market of Digital Respiratory Devices include



  • COHERO Health Inc.

  • Cognita Labs

  • Adherium Limited

  • Amiko Digital Health Limited

  • Teva Pharmaceuticals Industries Ltd.

  • Propeller Health

  • Novartis AG

  • Pneuma Respiratory Inc.

  • 3M Health Care Limited

  • AireHealth, Inc.

  • FindAir Sp. z o.o


Digital Respiratory Devices Industry Developments


July 2022 In order to provide access to pulse oximetry for anesthesia and critical care, Smile Train, Inc. and their long-time partner Lifebox introduced the Lifebox-Smile Train pulse oximeter.


Digital Respiratory Devices Market Segmentation


Digital Respiratory Devices Product Outlook



  • Smart Inhalers & Nebulizers

  • Sensors & Apps


Digital Respiratory Devices Indication Outlook



  • Asthma

  • COPD

  • Other Diseases


Digital Respiratory Devices Distribution Channel Outlook



  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies


Digital Respiratory Devices End Use Outlook



  • Hospitals

  • Homecare Settings

  • Other Settings


Digital Respiratory Devices Regional Outlook



  • North America

    • U.S.

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.